| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/23/2000 | EP0980874A1 Process for production of insulin precursors having correctly linked cystein bridges |
| 02/23/2000 | EP0980860A1 Optically active secondary alcohol and process for the production thereof |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980390A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes |
| 02/23/2000 | CN1245532A Reduction of phosphorus containing components in edible oils comprising high amount of non-hydratable phosphorus by use of phospholipase from filamentous fungus having phospholipase A and/or B activit |
| 02/23/2000 | CN1245502A DNA encoding lepidopteran-active delta-endotoxins and its use |
| 02/23/2000 | CN1245399A Method of biological control |
| 02/23/2000 | CN1245398A Method of biological control |
| 02/23/2000 | CN1245393A Hypersensitive response induced resistance in plants by seed treatment |
| 02/23/2000 | CN1049689C Method of producing L-glutamic acid by fermentation |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/22/2000 | US6028249 DNA sequences which lead to the formation of levans, plasmids containing these sequences as well as a process for preparing transgenic plants |
| 02/22/2000 | US6028246 Transformed plant cell, comprising in its genome, a dna sequence encoding a crystal protein which is toxic to lepidoptera |
| 02/22/2000 | US6028173 Amino acid sequence of polypeptide involved in axon outgrowth |
| 02/22/2000 | US6028097 Method of immunosuppression |
| 02/22/2000 | US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis |
| 02/22/2000 | US6027934 Nucleic acid and vectors encoding an immunodominant fragment of a unique protein antigen originally derived from trypanosoma brucei rhodesiense organisms can induce immunoprotection such as against trypanosomes, leishmania |
| 02/22/2000 | US6027926 Method of producing optically active 1,2,4-butanetriol |
| 02/22/2000 | US6027925 Production of non-native bacterial exopolysaccharide in a recombinant bacterial host |
| 02/22/2000 | US6027920 System for protein expression and secretion especially in corynebacteria |
| 02/22/2000 | US6027919 BMP-12 and BMP-13 proteins and DNA encoding them |
| 02/22/2000 | US6027918 Dna molecule encoding a thermostable enzyme from the genus sulfolobus; vectors and transformed host cells; releases trehalose from nonreducing saccharides having trehalose as an end unit and a degree of glucose polymerization of at least 3 |
| 02/22/2000 | US6027915 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
| 02/22/2000 | US6027910 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein |
| 02/22/2000 | US6027906 Dna molecules coding for the said penicillin binding protein (pbp) variants, as well as vectors containing them; assaying and designing therapeutically useful compounds which have high affinity to pbp |
| 02/22/2000 | US6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence |
| 02/22/2000 | US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders |
| 02/22/2000 | US6027875 Receptor infection assay |
| 02/22/2000 | CA2208707C Novel aminooligosaccharide derivative and process for preparing the same |
| 02/22/2000 | CA2091882C Gene therapy for cystic fibrosis |
| 02/22/2000 | CA2074214C Improvements in the in situ pcr |
| 02/22/2000 | CA1340910C Fibronectin binding protein |
| 02/22/2000 | CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/22/2000 | CA1340903C Process for stabilizing a plasmid present in a bacterial strain and strain thus obtained |
| 02/17/2000 | WO2000008198A1 Polyhydroxyalkanoate production from polyols |
| 02/17/2000 | WO2000008197A1 Method for the production of an antibiotic agent |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008182A1 Herpesvirus preparations and their uses |
| 02/17/2000 | WO2000008176A1 Mutated barnase gene and plant transformed by the same |
| 02/17/2000 | WO2000008164A2 Thermostable in vitro complex with polymerase activity |
| 02/17/2000 | WO2000008161A1 Transgenic plants with the expression of soybean glycinin |
| 02/17/2000 | WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | WO2000008142A2 Fibrous proteins and the production thereof |
| 02/17/2000 | WO2000008130A2 Method for preparing a cartilage cell suspension |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000007629A2 Peg-urate oxidase conjugates and use thereof |
| 02/17/2000 | WO2000007606A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | WO2000007432A1 Biodegradable high oxidative stability oils |
| 02/17/2000 | WO2000007431A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
| 02/17/2000 | WO1999061624A3 Polyhydroxyalkanoate biopolymer compositions |
| 02/17/2000 | WO1999058691A3 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 02/17/2000 | WO1999058643A8 Microorganism producing docosahexaenoic acid and phospholipase a1, liquid culture medium thereof, process for preparing phospholipid and process for producing 2-acyllysophospholipid |
| 02/17/2000 | WO1999051756A9 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 02/17/2000 | DE19834909A1 Faserproteine und ihre Herstellung Fibrous proteins and their preparation |
| 02/17/2000 | CA2362013A1 Transgenic plant expressing soybean glycinin |
| 02/17/2000 | CA2339643A1 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | CA2339365A1 Biodegradable high oxidative stability oils |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338185A1 Thermostable in vitro complex with polymerase activity |
| 02/17/2000 | CA2337968A1 Herpesvirus preparations and their uses |
| 02/17/2000 | CA2337963A1 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | CA2337861A1 A plant disease resistance signalling gene: materials and methods relating thereto |
| 02/17/2000 | CA2337741A1 Pancreatic and ovarian polypeptide, zsig58 |
| 02/17/2000 | CA2336592A1 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | CA2336064A1 Fibrous proteins and the production thereof |
| 02/17/2000 | CA2305784A1 Mutated barnase gene and plant transformed by the same |
| 02/16/2000 | EP0979876A2 Method for producing fermentative product and stress-resistant microorganism |
| 02/16/2000 | EP0979875A1 Plasmid derived from gluconobacter bacteria and vector |
| 02/16/2000 | EP0979873A1 Gene for petunia transcription factor PetSPL2 and its use |
| 02/16/2000 | EP0979302A1 Isolation of carotenoid crystals from microbial biomass |
| 02/16/2000 | EP0979299A1 Bioluminescent reporter bacterium and methods for toxicity monitoring in biological wastewater treatment systems |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979291A1 Methods of production of an amidated peptide through the use of a fusion protein |
| 02/16/2000 | EP0979276A1 Complement receptor type 1 (cr1)-like sequences |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0784605B1 Selective process for the deacylation of acylated compounds |
| 02/16/2000 | CN1244921A Treatment and diagnosis of cancer |
| 02/16/2000 | CN1244894A Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| 02/16/2000 | CN1244585A Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode |
| 02/16/2000 | CN1244502A Water purifying agent and water purifying method |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025465 Insulin-like growth factor binding protein (IGFBP-6) |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025204 Diagnostic method for detection of placental-derived prostate growth factors |
| 02/15/2000 | US6025188 Degrading a mycotoxin having a tricabyllic ester by contacting with an esterase enzyme; for treating grain, silage, food crops and animal feed |
| 02/15/2000 | US6025180 Asp1 |
| 02/15/2000 | US6025176 For diagnosis and monitoring of insulin dependent diabetes mellitis; antidiabetic agents |
| 02/15/2000 | US6025167 RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| 02/15/2000 | US6025164 Bacterial antigens and vaccine compositions |